Download PDFPDF

Antibiotic treatment and susceptibility testing
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Antibiotic treatment and susceptibility testing
    • Subhash C Arya, Clinical Microbiologist
    • Other Contributors:
      • Subhash C Arya, Nirmala Agfarwal

    Dear Editor,

    Kerr has succinctly outlined the events in the past six decades that assisted the clinicians in a judicious care of infectious diseases [1]. During the past decade several automated devices have been marketed that would reduce the turnaround period for bacteriological culture and susceptibility assays. While the majority of investigators found such systems to be so commendable, the recent controlled inve...

    Show More
    Conflict of Interest:
    None declared.